We designed our study to deliver BRCA1 and BRCA2 tumor suppressors in the form of plasmid by means of inorganic Carbonate Apatite (CA) nanoparticles (NPs) carrier and evaluated breast cancer cell growth both in vitro and in vivo. The gene discussed is BRCA1; the disease is neoplasm.